There is no excerpt because this is a protected post.
September 15, 2026
- GSK Commits $750M to Get Chimagen’s Phase 1-Ready Drug for Multiple Myeloma
- Civitas Conference to Feature Health Data Utilities, Community Information Exchanges
- The Real Bottleneck in U.S. Pharma Reshoring Isn’t Factories – It’s Talent
- Health Care Access and Affordability for Adults with Multiple or Complex Health Conditions: A Snapshot of Patient Experiences
Headlines
